PCN29 Time to Next Treatment As a Candidate Surrogate Endpoint for Overall Survival in Previously Untreated Advanced Melanoma Patients Treated with Immune-Checkpoint Inhibitors - Branchoux, S.; Sofeu, C.L.; Gaudin, A.F.; Kurt, M.; Moshyk, A.; Italiano, A.; Bellera, C.; Rondeau, V. (Value in health, 2020)